Cytokinetics Inc (CYTK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

280 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080

Focuses on the discovery, development and commercialization of novel small molecule drugs that target the cytoskeleton. As of March 2006, the company has small moleclue drug candidates in clinical development, and two in preclinical development.

Data based on most recent fiscal year report
Market Cap717.231 Million Shares Outstanding59.08 Million Avg Volume784.394 Thousand
1-Yr BETA vs S&P TR0.917 Current Ratio9.36 Quick Ratio9.36
View SEC Filings from CYTK instead.

View recent insider trading info

Funds Holding CYTK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYTK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.1 Million total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOMCY CHARLES J CHAIRMAN OF PHARMACEUTICALS

  • Officer
  • Director
1,302,291 2020-04-03 0

KAYE EDWARD M. MD CEO

  • Officer
  • Director
0 2020-03-25 4

BARBARI SHARON SURREY

  • Director
0 2020-03-19 0

SCHMERTZLER MICHAEL

  • Director
100,066 2020-03-16 0

CRAGG DAVID SVP HUMAN RESOURCES

  • Officer
139,098 2020-03-06 4

BLUM ROBERT I PRESIDENT & CEO

  • Officer
  • Director
313,610 2020-03-06 12

GAGE L PATRICK

  • Director
21,850 2020-03-06 3

MALIK FADY IBRAHAM EVP RESEARCH & DEVELOPMENT

  • Officer
156,621 2020-03-06 12

JAW CHING SVP FINANCE & CFO

  • Officer
73,165 2020-03-06 3

SCHLOSSBERG MARK A SVP - LEGAL & GENERAL COUNSEL

  • Officer
30,000 2020-03-06 1

WONG ROBERT VP, CHIEF ACCOUNTING OFFICER

  • Officer
13,004 2020-03-06 2

MCDADE MARK

0 2020-02-20 0

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
4,050,001 2020-02-18 0

MCDOWELL CARYN GORDON SVP, GC & SECRETARY

  • Officer
23,453 2020-02-15 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
424,419 2020-02-13 3

HENDERSON JOHN T

  • Director
0 2020-02-12 6

SMITH SANDFORD D

  • Director
0 2020-02-12 4

PARSHALL B LYNNE

  • Director
0 2020-02-12 2

CALIFF ROBERT

  • Director
0 2020-02-12 4

WIERENGA WENDALL

  • Director
0 2019-06-21 1

COSTA SANTO J

17,327 2019-06-13 1

RODDY PETER S SVP FINANCE & CAO

  • Officer
21,520 2018-02-27 0

MORGAN BRADLEY PAUL SVP DRUG DISCOVERY & EARLY DEV

  • Officer
46,441 2017-08-31 0

DOW STEPHEN M

  • Director
307,190 2017-07-18 0

WOLFF ANDREW A SVP & CMO

  • Officer
47,255 2017-02-28 0

CHARPENTIER BONNIE SVP REGULATORY & COMPLIANCE

  • Officer
29,004 2017-02-28 0

SCHNIEDERS ELISABETH SR. VP, BUSINESS DEVELOPMENT

  • Officer
43,919 2017-02-28 0

GILBERT DENISE

  • Director
0 2015-07-10 0

EASTERN CAPITAL LTD

  • 10% Owner
14,303,071 2012-06-20 0

SPUDICH JAMES A

  • Director
180,600 2011-05-18 0

MORGANS DAVID J JR EVP-PRECLINICAL R&D

  • Officer
42,000 2011-02-28 0

HEIDRICH A GRANT III

  • Director
0 2011-01-03 0

SABRY JAMES H

  • FORMER EXECUTIVE CHAIRMAN
No longer subject to file 2010-06-03 0

RABSON MICHAEL SVP BUSINESS DEV/LEGAL & GC

  • Officer
20,043 2009-12-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-03-06 A 8,825 $14.40 a 8,825 313,610.00 direct

JAW CHING - Officer SVP FINANCE & CFO

2020-03-06 A 9,592 $14.40 a 9,592 73,165.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-03-06 A 9,592 $14.40 a 9,592 139,098.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-03-06 A 10,854 $14.40 a 10,854 156,621.00 direct

SCHLOSSBERG MARK A - Officer SVP - LEGAL & GENERAL COUNSEL

2020-03-06 A 9,607 $14.40 a 9,607 30,000.00 direct

GAGE L PATRICK - Director

2020-03-06 S 8,000 $14.82 d 20,000 21,850.00 direct

WONG ROBERT - Officer VP, CHIEF ACCOUNTING OFFICER

2020-03-06 A 10,000 a 13,004 13,004.00 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-03-06 A 120,000 a 309,444 313,610.00 direct

JAW CHING - Officer SVP FINANCE & CFO

2020-03-06 A 30,000 a 73,165 73,165.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-03-06 A 30,000 a 139,098 139,098.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-03-06 A 50,000 a 156,621 156,621.00 direct

SCHLOSSBERG MARK A - Officer SVP - LEGAL & GENERAL COUNSEL

2020-03-06 A 30,000 a 30,000 30,000.00 direct

WONG ROBERT - Officer VP, CHIEF ACCOUNTING OFFICER

2020-03-06 A 14,410 $14.40 a 14,410 13,004.00 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-03-06 A 231,175 $14.40 a 231,175 313,610.00 direct

JAW CHING - Officer SVP FINANCE & CFO

2020-03-06 A 50,408 $14.40 a 50,408 73,165.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-03-06 A 50,408 $14.40 a 50,408 139,098.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-03-06 A 79,146 $14.40 a 79,146 156,621.00 direct

SCHLOSSBERG MARK A - Officer SVP - LEGAL & GENERAL COUNSEL

2020-03-06 A 50,393 $14.40 a 50,393 30,000.00 direct

WONG ROBERT - Officer VP, CHIEF ACCOUNTING OFFICER

2020-03-06 A 5,590 $14.40 a 5,590 13,004.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-02-28 F 1,384 $13.94 d 109,098 109,098.00 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-02-28 F 4,150 $13.94 d 189,444 193,610.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-02-28 F 2,075 $13.94 d 106,621 106,621.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-02-27 F 4,150 $13.94 d 110,482 110,482.00 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-02-27 F 13,832 $13.94 d 193,594 197,760.00 direct

JAW CHING - Officer SVP FINANCE & CFO

2020-02-27 F 2,767 $13.94 d 43,165 43,165.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-02-27 F 5,533 $13.94 d 108,696 108,696.00 direct

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2020-02-26 F 7,121 $14.07 d 114,229 114,229.00 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2020-02-26 F 16,681 $14.07 d 207,426 211,592.00 direct

CRAGG DAVID - Officer SVP HUMAN RESOURCES

2020-02-26 F 4,431 $14.07 d 114,632 114,632.00 direct

JAW CHING - Officer SVP FINANCE & CFO

2020-02-26 F 4,399 $14.07 d 45,932 45,932.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-02-13 S 486,344 $15.79 d 3,131,432 424,419.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-02-13 S 74,893 $15.79 d 424,419 424,419.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-02-13 S 510,793 $15.79 d 2,350,829 424,419.00 direct

CALIFF ROBERT - Director

2020-02-12 A 5,957 $15.43 a 5,957 0.00 direct

PARSHALL B LYNNE - Director

2020-02-12 A 2,749 $15.43 a 2,749 0.00 direct

HENDERSON JOHN T - Director

2020-02-12 A 6,415 $15.43 a 6,415 0.00 direct

SMITH SANDFORD D - Director

2020-02-12 A 4,124 $15.43 a 4,124 0.00 direct

KAYE EDWARD M. MD - Director

2020-02-12 A 8,248 $15.43 a 8,248 0.00 direct

Elevate your investments